Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 11,464.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,464.37% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,072.65% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 608.17% |
TMC the metals (TMC) | 458.77% |
Forward Industries (FORD) | 422.9% |
Opendoor Technologies (OPEN) | 390.46% |
Centrus Energy (LEU) | 359.23% |
Wolfspeed (WOLF) | 321.21% |
Celcuity LLC (CELC) | 273.68% |
Cidara Therapeutics (CDTX) | 253.23% |
SSR Mining (SSRM) | 246.88% |
American Bitcoin (ABTC) | 238.69% |
ViaSat (VSAT) | 232.95% |
GRAIL, LLC (GRAL) | 231.82% |
Sibanye Gold Ltd ADR (SBSW) | 229.62% |
Uniqure (QURE) | 227% |
Sandisk (SNDK) | 220.02% |
DRDGOLD Limited ADR (DRD) | 219.39% |
Planet Labs PBC (PL) | 217.36% |
Pagaya Technologies (PGY) | 212.2% |
Ondas (ONDS) | 208.8% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 207.54% |
Power Solutions International, Inc Common Stock (PSIX) | 206.46% |
CommScope (COMM) | 194.3% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
